MONMOUTH JUNCTION, N.J., Aug. 4, 2011 /PRNewswire/ —
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused
company using blood purification to treat life-threatening
illnesses, announced that it is exhibiting at the Advanced
Technology Applications for Combat Casualty Care (ATACCC)
Conference to be held at the Marriott Harbor Beach Conference
Center in Fort Lauderdale, Florida. CytoSorbents will be exhibiting
from August 15-18, 2011 in Booth #60. ATACCC is the Department of
Defenses’ premier scientific meeting that addresses critical
advances in trauma medicine and the unique medical needs of the
warfighter (
https://www.ataccc.org/). The conference is attended by
many of the top national and international military healthcare
leaders and physicians and reports on best practices for the
treatment of combat related injuries.
Dr. Phillip Chan, Chief Executive Officer and President,
commented, “When we exhibited at ATACCC last year, our
CytoSorb™ cytokine filter technology generated a lot of
interest and enthusiasm, as it was specifically designed to help
address the excessive inflammatory component associated with major
injuries that our warfighters sustain in combat including
polytrauma, infection and sepsis, and burns. This
inflammation, driven by cytokine storm, can often lead to multiple
organ failure, one of the leading causes of death in critically
injured patients. Our clinical trial in sepsis patients and
our European regulatory approval for CytoSorb™ have validated
the technology as a safe and effective cytokine filter that can be
used in life-threatening illnesses. This now opens up many
more opportunities for us, particularly for European military
applications, which we will actively pursue.”
Dr. Chan concluded, “Over the past year, we have also been
invited to present our technology to many different groups closely
i
‘/>”/>
SOURCE